Nanobiotix (NANO.PA) traded down -0.54 % during a 24 hours period ending at 07:50 PM Central Europe on Monday 26th. One Nanobiotix stock can currently be bought for about EUR 28.22 on popular exchanges. Current supply of Nanobiotix stocks is 50.9 mn. Nanobiotix has a current market capitalization of EUR 1.3 bn and approximately EUR 9.9 mn worth of Nanobiotix was traded on exchanges in the last 24 hours. Since last month end, Nanobiotix has traded -7.73 % down. Simple moving average of last 200 days is at EUR 28.98. The highest price of past 52 weeks was recorded at EUR 47.66 on 05/18/2026. 52 weeks low was at EUR 13.1 on 10/28/2025.

Here is how related stocks have performed in the past 24 hours:

  • Emeis (EMEIS.PA) traded down -0.26 % and now trades at EUR 9.77. Current market capitalisation for Emeis is EUR 1.6 bn.

  • Stef (STF.PA) traded up 0.51 % and now trades at EUR 121. Stef has a market capitalisation of EUR 1.5 bn. Stef has a current price to earnings ratio of 12.13.

  • Ca Nord De France-cci (CNDF.PA) traded down -1.2 % and now trades at EUR 23.3. Ca Nord De France-cci has a market capitalisation of EUR 1.3 bn. Ca Nord De France-cci has a current price to earnings ratio of 5.01.

  • Peugeot Invest (PEUG.PA) traded down -1.33 % and now trades at EUR 52. Current market capitalisation for Peugeot Invest is EUR 1.3 bn. Current price/earnings ratio for Peugeot Invest is 5.41.

  • Ipsos (IPS.PA) traded down -5.56 % and now trades at EUR 35.3. Ipsos has a market capitalisation of EUR 1.5 bn. Ipsos has a current price to earnings ratio of 8.81. Ipsos, a global market‑research firm, has released a survey indicating that consumers in the United States, France, Germany, Italy and China show a clear preference for natural fibres over synthetic ones. The study reports that the majority of respondents favour natural fabrics when price, style and fit are comparable, with merino wool preferred over polyester in all five markets. Respondents also expressed a willingness to pay a premium for clothing made mainly from natural fibres and highlighted the importance of independent certification of fibre content and quality. The findings underpin Woolmark’s new “Return to Real” campaign, which aims to promote the performance and sustainability of merino wool through a global branding effort.

About Nanobiotix

Nanobiotix SA is a late-stage clinical company that specializes in developing and selling nanomedicine for the treatment of cancer. The company, incorporated in 2003 and headquartered in Paris, France, has made it its mission to revolutionize cancer treatment by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Nanobiotix SA’s product line includes NBTXR3, a preclinical research program focused on cancer immunotherapies. The company’s cutting-edge technology, known as NanoXray, enhances the efficacy of radiotherapy by utilizing nanoparticles to deliver the radiation directly to the tumor, all while minimizing damage to nearby healthy tissues. This unique approach has made Nanobiotix SA a pioneer in the biotechnology sector, listed on both the NYSE and Euronext Paris exchanges. The official website for Nanobiotix SA is www.nanobiotix.com , and more information about their offerings can be found there.